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1130 The Journal of Thoracic and CardObjective: Recent studies have shown that perivascular adipose tissue from the rat
aorta secretes a substance that can dilate the aorta. The purpose of the present study
was to examine whether this vasodilator is also present in human internal thoracic
arteries.
Methods: Vascular function of human internal thoracic arteries with and without
perivascular adipose tissue was assessed with wire myography, and morphology
was examined with light microscopy.
Results: The presence of perivascular adipose tissue attenuated the maximal con-
traction to U 46619 and the contraction to phenylephrine (1 mol/L) by 37% and
24%, respectively. Transfer of the solution incubated with a perivascular adipose
tissue–intact vessel (donor) to a vessel without perivascular adipose tissue (recipi-
ent) induced a significant relaxation (36%) in the recipient artery precontracted with
phenylephrine. Transfer of incubation solution with perivascular adipose tissue
alone also induced a relaxation response in the recipient vessel (37%). The relax-
ation of the recipient artery induced by the transfer of incubation solution from the
donor (artery with intact perivascular adipose tissue or perivascular adipose tissue
alone) was absent in vessels precontracted by KCl (60 mmol/L) and was prevented
by calcium-dependent potassium channel blockers (tetraethylammonium chloride,
1 mmol/L; iberiotoxin, 100 nmol/L), but not by the voltage-dependent potassium
channel blocker 4-aminopyridine (1 mmol/L) and the adenosine triphosphate–
dependent potassium channel blocker glibenclamide (10 mol/L).
Conclusions: Perivascular adipose tissue in human internal thoracic arteries releases
a transferable relaxation factor that acts through the activation of calcium-dependent
potassium channels. Because perivascular adipose tissue is often removed in coro-
nary artery bypass grafting, retaining perivascular adipose tissue might be helpful in
reducing the occurrence of vasospasm of the graft vessels.
In addition to energy storage, adipose tissue secretes a significant number ofbiologically active substances, such as leptin, adiponectin, angiotensinogen,resistin, and steroid hormones.1,2 Most of the systemic blood vessels are
surrounded by a certain amount of perivascular adipose tissue (PVAT) situated
outside the adventitial layer. In rat aorta recent studies, including ours,3-5 have
reported that PVAT releases a relaxing factor that attenuates vascular contractile
responses to agonists, including serotonin, angiotensin II, and phenylephrine,
through the activation of potassium channels in vascular smooth muscle cells.
Hyperpolarization of smooth muscle cell membrane caused by potassium chan-
nel activation, as in the case of vascular response to endothelium-derived
hyperpolarizing factor (EDHF), is an important mechanism for vasodilation.6
However, the fact that rat aortic PVAT can release a relaxation factor does not
necessarily mean that PVAT in a human subject would function similarly
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Pbecause rodent aorta is surrounded by brown adipose
tissue that is absent in adult human subjects.7 Therefore
the clinical relevance of the finding in rats needs to be
examined in human vessels. The purpose of this study is
to examine whether this relaxation factor is also present
in the PVAT of human arteries.
Methods
Patients with coronary artery disease who underwent elective
coronary artery bypass grafting (CABG) were included in this
study. The study conforms to the principles outlined in the Dec-
laration of Helsinki, and institutional approval was obtained.
Vessel Preparation and Contractility Study
Terminal segments of human internal thoracic arteries (ITAs) that
were usually discarded during CABG were collected in oxygen-
ized (95% O2 and 5% CO2) physiologic salt solution at 4°C with
the following composition: NaCl, 119 mmol/L; KCl, 4.7 mmol/L;
KH2PO4, 1.2 mmol/L; MgSO4, 1.2 mmol/L; NaHCO3, 25 mmol/L;
CaCl2, 1.6 mmol/L; glucose, 11 mmol/L. Care was taken to ensure
minimal handling of the ITAs during operation to minimize dam-
age. The ITAs were transported to our laboratory within 60 min-
utes in physiologic salt solution on ice.
Paired ITA rings, one with intact PVAT (PVAT) and one with
PVAT removed (PVAT), were prepared from each segment. A
wired myograph system was used to study the contraction and
relaxation responses of the ITAs, as described in our previous
report.8 ITAs with or without PVAT were studied at the same basal
tension. After equilibration for at least 60 minutes, the ITA was
challenged with 60 mmol/L KCl twice at an interval of 30 minutes
to check the viability of the tissue. Concentration-contraction
response curve for U 46619 (0.3-300 nmol/L) was constructed and
expressed as a percentage of KCl contraction. The concentration
that causes 50% of the maximal contraction was estimated by
fitting each concentration-response curve. Relaxation response to
sodium nitroprusside was tested in ITAs precontracted with phenyl-
ephrine (1-3 mol/L) and expressed as a percentage of the precon-
traction value.
Bioassay Experiments and Morphologic Study
The effects of the relaxing factor released by PVAT were studied
in the following way. The donor aliquot was incubated either with
ITAs with intact PVAT or with PVAT alone for 20 to 25 minutes
and then transferred to the recipient ITAs with PVAT removed.
The donor and the recipient ITAs were simultaneously contracted
with the same contracting agent (1 mol/L phenylephrine or
60 mmol/L KCl), and the transfer of the aliquot was carried out
when the contraction of the donor and recipient arteries had
reached a plateau. The capacity of the organ bath tube was 4 mL,
and the amount of aliquot transferred was 3 mL. The relaxation of
the recipient ITAs was expressed as a percentage of the precon-
traction value. Ion channel blockers were introduced when the
relaxation response had reached a plateau. Some ITAs were fixed
in 10% formalin for morphologic studies. Cross-sections of ITAs
were stained with hematoxylin and eosin or Gomori trichrome for
light microscopy.
The Journal of ThoracicStatistical Analyses
Results are presented as means  standard error of the mean.
Statistical analyses were carried out with SigmaStat (SPSS, Inc,
Chicago, Ill). Before statistical testing, normality was examined
for all the data, and the minimum P value was .072. The Student
t test was used to identify the contractile difference between
vessels with or without PVAT in response to KCl and to phenyl-
ephrine. The paired t test was used to assess the relaxation re-
sponse of the ITAs (PVAT) to transfer of aliquot from ITAs
(PVAT) and from PVAT alone. Two-way repeated-measures
analysis of variance (ANOVA) was used to determine any signif-
icant difference between the concentration responses to U 46619 in
ITAs with or without PVAT. Post hoc t tests were used to identify
the concentration at which statistically significant differences oc-
curred, when ANOVA indicated significant differences between
PVAT and PVAT ITAs. One-way repeated-measures ANOVA
was used to assess the effects of K channel blocker on the
relaxation caused by aliquot transfer.
Results
Patient Characteristics
ITAs from a group of 52 patients consisting mostly of male
subjects were studied (Table 1). The average age was 62.8
years, with a range of 43 to 82 years. Forty-six percent of
them were overweight, and 38% were obese. Eighty-one
percent of them were smokers. Of the patients, 92.3% had 1
or more risk factors for coronary heart disease, and 96.2%
were receiving 1 or more type of medication for hyperten-
TABLE 1. Patient characteristics, including risk factors
and medications
Physical factors
Number 52
Men, n (%) 44 (85)
Women, n (%) 8 (15)
Age (y) 62.8  1.3
Height (cm) 172.2 1.1
Weight (kg) 87.4 2.1
Overweight, n (%), BMI 25-29.9 24 (46)
Obese, n (%), BMI 30 20 (38)
Health factors, n (%)
Hypertension 32 (62)
Diabetes mellitus 24 (46)
Hypercholesterolemia 26 (50)
Smoker 42 (81)
Myocardial infarction 39 (75)
Medications, n (%)
Aspirin 33 (63)
Clopidogrel 14 (27)
-Blockers 39 (75)
ACE inhibitors 37 (71)
Calcium channel blockers 21 (40)
Statin 35 (67)
Nitrates 43 (83)
BMI, Body mass index; ACE, angiotensin-converting enzyme.sion, hypercholesterolemia, antianginal therapy, and anti-
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treated with papaverine during harvesting. Correlation anal-
ysis did not show any relation between the contraction or
relaxation response with the patient parameters nor with
papaverine treatment (data not shown).
Morphology and Contractile-Relaxation Response
The human ITA is surrounded by a significant amount of
PVAT consisting of white adipose tissue (Figure 1, A)
compared with the PVAT of rat aorta, which consists of
mostly brown adipose tissue (Figure 1, B). The contraction
Figure 1. Cross-sections of a human internal thoracic artery (A)
and a rat aorta (B) showing the perivascular adipose tissue
(PVAT) outside the adventitial layer. Perivascular adipose tissue
in human subjects is composed of white adipose tissue compared
with brown adipose tissue in rat aortas. SMC, Smooth muscle
cell layer. (Magnification bar represents 100 m).of ITA in response to KCl (60 mmol/L) was not affected by
1132 The Journal of Thoracic and Cardiovascular Surgery ● Octthe presence or removal of PVAT (Table 2). Similarly, the
relaxation response of ITAs to sodium nitroprusside was
also not affected by the removal of PVAT. U 46619, a
thromboxane A2/prostaglandin H2 receptor agonist, induced
a concentration-related contraction of the ITA. The presence
of PVAT significantly attenuated the contractile response to
U 46619 (P .001, n 5-7 for each), with a 37% reduction
of the maximal contraction (Figure 2 and Table 2), but the
value inducing 50% of the maximal contraction was similar
between PVAT and PVAT arteries (3.66  0.86 nmol/L
in PVAT ITAs vs 3.56 0.76 nmol/L in PVAT ITAs; n
7, P  .9). Contraction of ITAs to 1 mol/L phenylephrine
was 23.4% lower in vessels with PVAT than in those
without PVAT (Table 2). When the contraction to phenyl-
ephrine had reached a plateau, transfer of bathing solution
from ITAs with PVAT to ITAs without PVAT induced a
relaxation response in the recipient vessel (36% reduction of
tension; Figure 3, A and B). The same transfer procedure
between ITAs with PVAT removed did not induce any
relaxation response in the recipient vessel (Figure 3, C).
Transferring the aliquot incubated with PVAT alone pro-
duced a similar relaxation response in the recipient ITAs
(37%) as in ITAs with intact PVAT (before transfer, 120% 
39%; after transfer, 76%  30%; n  5, P  .014). The
transfer of solution incubated with PVAT-intact ITAs did
not induce relaxation of the recipient ITAs (with PVAT
removed) when the ITA was precontracted with 60 mmol/L
KCl (before transfer, 2.5  0.4 tension in grams; after
transfer, 2.5  0.3 tension in grams; n  4, P  .37). The
relaxation induced by transfer of aliquots incubated with
PVAT-intact ITAs was reversed by the calcium-dependent
K channel blocker tetraethylammonium chloride (1 mmol/
L), but not by the voltage-dependent K channel blocker
4-aminopyridine (1 mmol/L) and the adenosine triphosphate
(ATP)–dependent K channel blocker glibenclamide (10
mol/L; Figure 4). Iberiotoxin (107 mol/L) mimicked the
effects of tetraethylammonium chloride. Heating the ali-
quots incubated with PVAT-intact ITAs (65°C for 10 min-
utes) rendered the relaxation factor ineffective, and cyclo-
oxygenase inhibitor (diclofenac, 105 mol/L) and nitric
oxide synthase inhibitor (N-nitro-L-arginine, 104 mol/L)
did not affect the relaxation effects (data not shown).
Discussion
To our knowledge, this is the first report that PVAT in
human ITAs produces a transferable vasodilating factor, as
shown previously in rat aortas. However, the mechanism for
the relaxation by this factor is the activation of calcium-
dependent K channels in human ITAs, which is in contrast
to the activation of ATP-dependent K channels in rat
aortas. The presence of PVAT attenuated the contractile
response to agonists (U 46619 and phenylephrine) in human
ober 2005
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PITAs. These results suggest that PVAT might play a signif-
icant role in the regulation of human vessel tone in vivo.
Endothelium has been recognized as a major regulator of
vessel function by releasing various relaxation factors, in-
cluding nitric oxide and EDHF, and vasoconstrictors, such
as endothelin. The possible contribution of PVAT in mod-
ulating vessel tone had largely been neglected until recently
because in functional studies with isolated vessels, PVAT is
routinely removed. This is probably because of the concern
that PVAT might interfere with the diffusion of the test
agents to the vessel wall and that this might affect the
response of the blood vessels. Because the contractile re-
sponse of the ITA to KCl or their relaxation response to
sodium nitroprusside was similar between PVAT and
PVAT ITAs, the presence of PVAT does not seem to impose
any mechanical restraint on the ability of the ITA to contract or
relax. However, compared with the responses of PVAT
ITAs, the contractile response of PVAT ITAs to agonists
such as U 46619 and phenylephrine was attenuated. This
suggested that a relaxation factor is released from PVAT
that interferes with the contractile response of the ITA. The
notion that a relaxing factor is released by PVAT is sup-
ported by the results from our bioassay experiments, which
showed that the transfer of bathing solution from ITAs with
intact PVAT or PVAT alone to ITAs with PVAT removed
caused a relaxation response in the recipient ITAs. The
attenuation of the contraction to U 46619 by PVAT might
be of particular importance because thromboxane A2 is a
potent vasoconstricting agent in the ITA.8,9 The thrombox-
ane A2 level is increased during cardiopulmonary bypass10
and might thus play a role in vasospasm of the graft artery.11
To identify the mechanisms for this relaxation factor from
human ITAs, we have focused on K channels on the basis
of the study in rat aortas in which the activation of ATP-
dependent K channels was suggested to be the mechanism
involved.4 Our results showed that in human ITAs the
activation of calcium-dependent K channels is involved
instead of the ATP-dependent K channels because the
calcium-dependent K channel blockers tetraethylammo-
nium chloride and iberiotoxin effectively blocked the relax-
TABLE 2. The effects of the presence or absence of pe
responses of human internal thoracic arteries
Contractile response
KCl (60 mmol/L; g)
Phenylephrine (1 mol/L; % of KCl)
U 46619 (0.3 mol/L; % of KCl)
Relaxation response
Sodium nitroprusside (30 mol/L; % of precontraction)
PVAT, Absence of perivascular adipose tissue; PVAT, presence of peation response induced by the bathing solution from ITAs
The Journal of Thoracicwith intact PVAT. Voltage-dependent or ATP-dependent K
channels do not seem to be involved because 4-aminopyridine,
which affects voltage-dependent K channels, and gliben-
clamide, which affects ATP-dependent K channels, did not
affect this relaxation response. It has been reported that EDHF
induces relaxation through activation of calcium-dependent
K channels in human ITAs.6 Therefore PVAT-derived
relaxation factor showed some similarity to EDHF in its
action.
The identity of the PVAT-derived relaxation factor re-
mains unclear. The lack of effects of cyclooxygenase or
nitric oxide synthase inhibitor on this relaxation factor has
scular adipose tissue on the contractile and relaxation
PVAT PVAT n P value
2.5 0.3 2.6 0.3 18 .76
06 6.7 81 7.9 18 .023
95 41 185 15 7 .026
99 7.3 98 6.7 7 .9
ular adipose tissue.
Figure 2. Concentration-response curve to U 46619 in perivascu-
lar adipose tissue–intact (PVAT) and perivascular adipose
tissue–denuded (PVAT) preparations of human internal tho-
racic arteries. Contraction to U 46619 was attenuated in perivas-
cular adipose tissue–intact preparations (P < .001, 2-way
ANOVA). The maximal contraction to U 46619 was reduced in
perivascular adipose tissue–intact arteries (P  .026, n  7 forriva
1
2each).
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or nitric oxide. Adipocytes produce a number of adipo-
kines,1,2 and some of the adipokines, such as angiotensino-
gen, might have the potential to regulate vessel function.
The fact that this relaxation factor is deactivated by heating
suggests that this might be a peptide, which is similar to the
finding by Lohn and associates.4
The types of adipose tissue surrounding rat aorta and
Figure 3. Transferring aliquots incubated with perivascular adipose
tissue-intact human internal thoracic artery tissue to perivascular
adipose tissue-denuded preparations induced a marked relaxation
in the recipient artery. A, Typical relaxation response of recipient
artery; B, a summary of relaxation response (**P < .001 vs tension
before transfer, n  18 for each); and C, transfer of aliquot between
perivascular adipose tissue-denuded arteries in the control subjects
(P  .55, n  4 for each).human ITAs are different, being brown in rats and white in
1134 The Journal of Thoracic and Cardiovascular Surgery ● Octhuman subjects. However, our present study in human ITAs
and previous studies in rat aortas suggested that both brown
and white PVAT has the ability to produce a relaxation
factor. The difference in the subtypes of K channels acti-
vated by this factor might represent difference between
brown and white PVAT or the density of different subtypes
of K channels in human vessels versus rat aortas.
The human ITA is a better graft choice than veins in
CABG in terms of graft patency and patient survival12
because of its high resistance to atherosclerosis.13 However,
one complication with the use of the ITA is the occurrence
of vasospasm,14,15 which might occur during or after surgi-
cal intervention and might result in myocardial infarction
and postoperative morbidity.16 The mechanisms of the
spasm are not fully understood, but surgical trauma–
induced release of various vasoconstricting substances, re-
Figure 4. Effects of potassium channel blockers on relaxation
response of perivascular adipose tissue-denuded human internal
thoracic arteries induced by aliquot transfer from perivascular
adipose tissue-intact arteries. A, Typical recording showing tet-
raethylammonium chloride (TEA) reversed the relaxation; B, sum-
mary of the effects of various K channel blockers. Tetraethyl-
ammonium chloride (**P < .001, n  13), but neither
4-aminopyridine (4-AP; P  .98, n  3) nor glibenclamide (P  .91,
n  3), reversed the relaxation response.duced production of vasodilating substances, or both might
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agents are used to counteract the spasm or to dilate the
ITA,14 but some of these agents, such as papaverine, are
harmful to endothelial and smooth muscle cells.8,17 Al-
though the long-term consequence of the damage to vascu-
lar tissue by papaverine is not known, it is prudent to
develop alternatives to prevent the occurrence of the spasm.
We suggest, on the basis of the present study, that retaining
PVAT in the ITA for CABG might help to alleviate the
contraction of the ITA to stimulating agents and therefore
might be helpful in reducing the occurrence of vasospasm.
During CABG, the ITA is harvested either as a pedicle
with the surrounding tissues intact, which include the veins,
lymphatics, and nerves, or these tissues are removed in a
process known as skeletonization, as first described by
Keeley18 in 1987. The advantages of the skeletonization
procedure are longer vessel length for grafting and mini-
mized chest-wall trauma with reduced risk of sternal wound
infection because vein, muscle, and accompanying endotho-
racic tissues are left in place and collateral sternal blood
supply is preserved. Blood flow was reported to be higher in
skeletonized ITAs than in pedicled ITAs after surgical in-
tervention.19-22 Most of the long-term follow-up studies of
patients who underwent CABG involving skeletonized ITAs
were focused on postoperative mortality and morbidity,23
safety in elderly patients,24,25 and diabetic and obese pa-
tients.26,27 However, it remains to be determined whether
the presence of PVAT in ITAs will confer additional long-
term benefits to the patient in terms of vascular integrity and
functions. The presence of PVAT might be more advanta-
geous to more reactive arteries, such as radial arteries, than
ITAs to enhance vessel relaxation after CABG.
In summary, we have demonstrated here for the first time
that PVAT attenuates human ITA contraction by releasing a
transferable relaxing factor that activates calcium-dependent
K channels. This understanding will not only add new insight
to the regulation of vascular tone in the human ITA but might
have potential implications in our efforts to prevent vasospasm
of the ITA during and after CABG. We suggest that retaining
PVAT in ITA grafts might help to alleviate wall tension by
preserving the production of this relaxation factor from PVAT
and also might help to reduce surgical trauma to the graft
tissue. Prevention of vasospasm and improvement of blood
flow will have a major benefit in strategies aimed at increasing
the long-term patency of such grafts.
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